X

Xenon Pharmaceuticals

D
XENE
USD
0.76
(1.6908%)
Market Closed
11,960.00
Volume
-3.11
EPS
-
Div Yield
-16.743590
P/E
3,463,195,523.55
Market Cap
Today
2.9968%
1 Week
11.189%
1 Month
12.475%
6 Months
5.347%
12 Months
43.878%
Year To Date
-0.674%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
X
XNCR
0.52
(2.2907%)
USD
N
NBIX
-1.26
(-1.0054%)
USD
S
SRPT
-2.57
(-2.0903%)
USD
ALNY
ALNY
-0.795
(-0.2913%)
USD
R
RARE
-0.1
(-0.1979%)
USD
S
SGEN
(%)
USD
B
BLUE
-0.0615
(-14.0764%)
USD
GILD
GILD
6.23
(6.7946%)
USD
VRTX
VRTX
9.22
(1.869%)
USD
B
BIIB
-4.13
(-2.3197%)
USD

Title:
Xenon Pharmaceuticals

Sector:
Healthcare
Industry:
Biotechnology
Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.
Do you need help or have a question?
Contact Us